Merck (MRK) Other Non Operating Income (2009 - 2026)

Merck (MRK) has reported Other Non Operating Income for 18 consecutive years, with -$99.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 1514.29% year-over-year to -$99.0 million in Q2 2026; TTM through Jun 2026 was -$431.0 million, a 659.74% decrease from a year earlier, with the FY2025 full-year figure at -$151.0 million, down 729.17% from the prior year.
• Other Non Operating Income was -$99.0 million for Q2 2026 at Merck, up from -$138.0 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $238.0 million in Q3 2025 and troughed at -$708.0 million in Q1 2022.
• A 5-year average of -$129.3 million and a median of -$94.0 million in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income soared 228.57% in 2024 and plunged 1514.29% in 2026, its largest moves.
• Over 5 years, Other Non Operating Income stood at $75.0 million in 2022, then slumped by 204.0% to -$78.0 million in 2023, then tumbled by 62.82% to -$127.0 million in 2024, then tumbled by 240.16% to -$432.0 million in 2025, then surged by 77.08% to -$99.0 million in 2026.
• The last three Other Non Operating Income figures came in at -$99.0 million (Q2 2026), -$138.0 million (Q1 2026), and -$432.0 million (Q4 2025), per Business Quant data.